---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-097090"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T00:59:06.094362+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# INmune Bio releases new investor presentation; no financial updates in filing

## Summary
- Company furnished a slide deck for use in investor presentations (Exhibit 99.1).
- Deck posted on company website under 'Investors – Corporate Presentation' section.
- Filing contains no new financial results, clinical data, or guidance changes.
- Presentation includes forward-looking statements; no material events disclosed.

## SEC filing metadata
- accession: 0001213900-24-097090
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390024097090/0001213900-24-097090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390024097090/ea0220968-8k_inmunebio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-097090
- JSON: https://secwatch.observer/filing/0001213900-24-097090.json
- Plain text: https://secwatch.observer/filing/0001213900-24-097090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.